Corami Biotech

Funding and NIH signals

• SEC Form D raise Raised $230K (Form D filed Apr 22, 2026). SEC Form D 0002042505-26-000003 (Apr 22, 2026)
  Evidence (1 event)

  • Apr 22, 2026 · SEC Form D 0002042505-26-000003
    Name of Issuer: Corami Biotech Inc.; CIK: 2042505; Address: Memphis, TN; Submission type: D; Filing date: 2026-04-22; Industry Group: Biotechnology; Date of First Sale: 2026-02-04; Types of Securities Offered: Option/warrant; Business combination transaction: false; Total Offering Amount: 1000000; Total Amount Sold: 230000; Federal exemptions: 06b
• NIH award NIH awarded $1.16M (STTR Phase II 5R42HL149495-03, continuation, notice Sep 9, 2026). NIH RePORTER 5R42HL149495-03 (Sep 9, 2026)
  Evidence (1 event)

  • Sep 9, 2026 · NIH RePORTER 5R42HL149495-03
    Organization: CORAMI BIOTECH INC.; City/State: MEMPHIS, TN; Project number: 5R42HL149495-03; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-09-09; FY total cost (award amount): 1164977; Administering IC: National Heart Lung and Blood Institute; Project title: Minimally Invasive Local Delivery of Cardiac Gene Therapy; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals